$BLU - BELLUS Health Stock Surges After Positive Data From Refractory Chronic Cough Trial. Stock almost hit double digits. Looking for break of $9
$Sigmatron International (SGMA.US)$ - ON Friday Company reported Q2 EPS $0.69 Up From $0.15 YoY, Sales $100.20M Up From $69.62M YoY. needs to hold $13 support level
$Eagle Pharmaceuticals (EGRX.US)$ - Eagle is seeking approval for a generic version of Vasostrict, which is marketed by (ENDP) Par unit and had total U.S. sales of $786 million in 2020.
$Lucid Group (LCID.US)$ - stock bouncing off $35 support as expected. Looking for break of $40 to keep moving higher.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more